2-Deoxy-2-fluoro-d-glucose as a functional probe for NMR: The unique metabolism beyond its 6-phosphate

Journal of Neurochemistry

Volumn 66, Issue 5, 1996, Pages 2113-2120

  Kanazawa, Y ^a   Yamane, H ^b,c   Shinohara, S ^a,d   Kuribayashi, S ^a,e   Momozono, Y ^a,f   Yamato, Y ^a   Kojima, M ^a,g   Masuda, K ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Chikuho Rosai Hospital   (Japan)

^d SHIONOGI AND CO LTD   (Japan)

^e DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^f The University of Kitakyushu   (Japan)

^g Nishina Memorial Cyclotron Center   (Japan)

Author keywords

2 Deoxy 2 fluoro D glucose; 2 Deoxy 2 18F fluoro D glucose; 19F NMR; Brain activity; Mouse; NMR quantification

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; METABOLISM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PENTOSE PHOSPHATE CYCLE; PHOSPHATE TRANSPORT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAXATION TIME;

EID: 0029936449     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66052113.x     Document Type: Article

References (37)

1. Alavi A., Newberg A.B., Souder E., and Berlin J. A. (1993) Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J. Nucl. Med. 34, 1681-1687.
2. Bessell E. M. and Thomas P. (1973) The deoxyfluoro-D-glucopyranose 6-phosphates and their effect on yeast glucose phosphate isomerase. Biochem. J. 131, 77-82.
3. Bessell E. M., Foster A B., and Westwood J. H. (1972) The use of deoxyfluoro-D-glucopyranose and related compounds in a study of yeast hexokinase specificity. Biochem. J. 128, 199-204.
4. Bida G. T., Sastyamurthy N., and Barrio J. (1984) The synthesis of 2-[F-18]-fluoro-2-deoxy-D-glucose using glycals: a reexamination. J. Nucl. Med. 25, 1327-1334.
5. Crane P. D., Pardridge W. M., Braun L. D., and Oldendorf W. H (1983) Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain. J. Neurochem 40, 160-167.
6. 14C]glucose in rat brain in vivo: influence of time and tissue glucose level. J. Neurochem. 60, 2217-2231.
7. Diksic M. and Jolly D. (1986) Synthesis of 2-deoxy-2-fluorohexoses by fluorination of glycals in aqueous media. Carbohydr Res. 153, 17-24.
8. Fukuyama H., Ogawa M., Yamauchi H., Yamaguchi S., Kimura J., Yonekura Y., and Konishi J. (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 1-6.
9. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J. Nucl. Med. 18, 990-996.
10. Gould K. L., Yoshida K., Hess M. J., Haynie M., Mullani N., and Smalling R. W. (1991) Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J. Nucl. Med. 32, 1-9.
11. Gritters L. S., Francis I. R., Zasadny K. R., and Wahl R. L. (1993) Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J. Nucl. Med. 34, 1420-1427.
12. Haberkorn U., Strauss L. G., Dimitrakopoulou A., Seiffert E., Oberdorfer F., Ziegler S., Reisser C., Doll J., Helus F., and van Kaick G. (1993) Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J. Nucl. Med. 34, 12-17.
13. Haradahira T., Maeda M., Omae H., Yano Y., and Kojima M. (1984) Synthesis of 2-deoxy-2-fluoro-D-mannose using fluoride ion. Chem. Pharm. Bull. (Tokyo) 32, 4758-4766.
14. Haradahira T., Maeda M., Kai Y., and Kojima M. (1985) A new, high yield synthesis of 2-deoxy-2-fluoro-D-glucose. J. Chem. Soc. Chem. Commun. 1985, 364-365.
15. Herholz K., Parani D., Salmon E., Franck G., Fazio F., Heiss W.-D., and Comar D. (1993) Comparability of FDG PET studies in probable Alzheimer's disease. J. Nucl. Med. 34, 1460-1466.
16. Horton R. W., Meldrum B. S., and Bachelard H. S. (1973) Enzymic and cerebral metabolic effects of 2-deoxy-2-glucose. J. Neurochem. 21, 507-520.
17. Kanazawa Y., Momozono Y., Ishikawa M., Yamada T., Yamane H., Haradahira T., Maeda M., and Kojima M. (1986) Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR. Life Sci. 39, 737-742.
18. Kanazawa Y., Momozono Y., Yamane H., Haradahira T., Maeda M., and Kojima M. (1987) NMR evidence for the unexpected interconversion of 2-deoxy-2-fluoro-D-glucose and 2-deoxy-2-fluoro-D-mannose in mice. Chem. Pharm. Bull. (Tokyo) 35, 895-897.
19. 19F NMR study of 2-deoxy-2-fluoro-D-glucose metabolites beyond FDG-6-phosphate and FDM-6-P in tumors. (Abstr.) Soc. Magn. Reson. Med. Ann. Meet. 2, 988.
20. Kanazawa Y., Yamada M., Umayahara K., Masuda K., and Yamashita T. (1994) The mechanism of FDG retention in heart and tumor, in Clinical PET in Oncology (Matsuzawa T., ed), pp. 63-66. World Scientific, Singapore.
21. Knuuti M. J., Nuutila P., Ruitsaalainen U., Teras M., Saraste M., Harkonen R., Ahonen A., Wegelius U., Haapanen A., Bergman J., Haaparanta M., and Viopio-Pulkki L.-M. (1993) The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J. Nucl. Med. 34, 2068-2075.
22. Kojima M., Kuribayashi S., Kanazawa Y., Haradahira T., Maehara Y., and Endo H. (1988) Metabolic pathway of 2-deoxy-2-fluoro-D-glucose and 2-deoxy-2-fluoro-D-mannose in mice bearing Sarcoma 180 studied by fluorine-19 nuclear magnetic resonance. Chem. Pharm. Bull. (Tokyo) 36, 1194-1197.
23. Lucignani G., Schmidt K. C., Moresco R. M., Striano G., Colombo F., Sokoloff L., and Fazio F. (1993) Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure. J. Nucl. Med. 34, 360-369.
24. Mansfield P. and Morris P. G. (1982) NMR imaging in Biomedicine, pp. 65-77. Academic Press, London.
25. 19F NMR spectroscopy. Biochem. Arch. 2, 53-61.
26. 19F nuclear magnetic resonance spectroscopy. J. Neurochem. 46, 198-201.
27. Nakada T., Kwee I. L., Card P. J., Matwiyoff N. A., Griffey B. V., and Griffey R. H. (1988a) Fluorine-19 NMR imaging of glucose metabolism. Magn. Reson. Med. 6, 307-313.
28. Nakada T., Kwee I. L., Griffey B. V., and Griffey R. H. (1988b) F-19 MR imaging of glucose metabolism in the rabbit. Radiology 168, 823-825.
29. 19F-NMR spectroscopy. Appl. Radiat. Isot. 37, 695-701.
30. 19F NMR spectroscopy NMR Biomed. 4, 161-166.
31. Schmidt M. F. G., Schwarz R. T., and Scholtissek C. (1974) Nucleoside-diphosphate derivatives of 2-deoxy-D-glucose in animal cells. Eur. J. Biochem. 49, 237-247.
32. 19F spectroscopic study of 2-deoxy-2-fluoro-D-glucose for in vivo tumor imaging. (Abstr.) Proc. Soc. Magn. Reson. 3, 1156.
33. 19F NMR: the effect of anesthesia. Magn Reson. Med. 21, 191-196.
34. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
35. Strauss L. G. and Conti P. S. (1991) The applications of PET in clinical oncology. J. Nucl. Med. 32, 623-648.
36. 18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies. Nucl. Med. Biol. 13, 577-581.
37. 18F-2-fluoro-2-deoxy-D-glucose. Eur. J. Nucl. Med. 10, 341-345.